| 000 | 01637 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250514220348.0 | ||
| 264 | 0 | _c20050322 | |
| 008 | 200503s 0 0 eng d | ||
| 022 | _a1528-3593 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGrosenbaugh, D A | |
| 245 | 0 | 0 |
_aComparison of the safety and efficacy of a recombinant feline leukemia virus (FeLV) vaccine delivered transdermally and an inactivated FeLV vaccine delivered subcutaneously. _h[electronic resource] |
| 260 |
_bVeterinary therapeutics : research in applied veterinary medicine _c2004 |
||
| 300 |
_a258-62 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Cutaneous |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntigens, Viral _xblood |
| 650 | 0 | 4 | _aCats |
| 650 | 0 | 4 |
_aInjections, Subcutaneous _xveterinary |
| 650 | 0 | 4 |
_aLeukemia Virus, Feline _ximmunology |
| 650 | 0 | 4 |
_aLeukemia, Feline _xprevention & control |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 |
_aRetroviridae Proteins, Oncogenic _xadministration & dosage |
| 650 | 0 | 4 | _aSafety |
| 650 | 0 | 4 | _aSpecific Pathogen-Free Organisms |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVaccination _xveterinary |
| 650 | 0 | 4 |
_aVaccines, Inactivated _xadministration & dosage |
| 650 | 0 | 4 |
_aVaccines, Synthetic _xadministration & dosage |
| 650 | 0 | 4 |
_aViral Vaccines _xadministration & dosage |
| 700 | 1 | _aLeard, T | |
| 700 | 1 | _aPardo, M C | |
| 700 | 1 | _aMotes-Kreimeyer, L | |
| 700 | 1 | _aRoyston, M | |
| 773 | 0 |
_tVeterinary therapeutics : research in applied veterinary medicine _gvol. 5 _gno. 4 _gp. 258-62 |
|
| 999 |
_c15394643 _d15394643 |
||